Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining -15.83% today. In the last week its performance is 0.88%, and 6.42% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 77.5, so today’s gain of -15.83% is a significant step towards its target price. The GAP today is therefore -17.68%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 125784.4, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.70%.

At the current price of 63.4, it has a dividend yield of 2.02%, and its target price is 77.5. This is with a profit margin of 17.00%, and total debt/equity of 0.45. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 80.47, as well as a forward P/E of 22.98.

With a current EPS of 0.94, and a forecasted EPS growth for next year at 25.56%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 23.34%.

Performance for the year is 18.46%. Since its IPO date on 6/1/1972, the total performance to date is 10.73%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 50663668, while its average volume is 5579.25. Whilst the total gain today was -15.83%, it did have a day high of -17.80%.

Volatility for this week has been at 1.49%, and 1.43% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 25.18%, while the 52-week-high has reached -17.80%.

Looking at its return of investments, which is 4.60%, and its return on assets is 9.00%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 21.70%. With a sales growth of 17.00% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.44, and has a current ratio of 1.6 and 1.4 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 3.45, and the P/S is 7.44, along with a P/B of 8.43. Meanwhile it has a p/cash of 27.04.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment